Sana Biotechnology Future Growth
Future criteria checks 0/6
Sana Biotechnology's earnings are forecast to decline at 3.8% per annum while its annual revenue is expected to grow at 83.6% per year. EPS is expected to grow by 6.1% per annum. Return on equity is forecast to be -75.4% in 3 years.
Key information
-3.8%
Earnings growth rate
6.1%
EPS growth rate
Biotechs earnings growth | 28.4% |
Revenue growth rate | 83.6% |
Future return on equity | -75.4% |
Analyst coverage | Low |
Last updated | 04 Sep 2024 |
Recent future growth updates
Recent updates
Sana Biotechnology: Early-Stage Biotech With Promising Allogeneic CAR-T Pipeline
Jul 14We're Keeping An Eye On Sana Biotechnology's (NASDAQ:SANA) Cash Burn Rate
Jul 12Sana Biotechnology: Now In Overbought Territory
Mar 17Sana Biotechnology's One-And-Done Solution For Diabetes Impresses In NHP Model (Rating Upgrade)
Jan 11Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans?
Dec 30Here's Why We're Watching Sana Biotechnology's (NASDAQ:SANA) Cash Burn Situation
Sep 14Will Sana Biotechnology (NASDAQ:SANA) Spend Its Cash Wisely?
May 26We're Keeping An Eye On Sana Biotechnology's (NASDAQ:SANA) Cash Burn Rate
Dec 19Here's Why We're Watching Sana Biotechnology's (NASDAQ:SANA) Cash Burn Situation
Sep 03Sana Biotechnology A Buy For Potential Cancer Therapies
Jun 27Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans?
May 16Sana Biotechnology: Exciting Preclinical Science
Feb 12Is Sana Biotechnology, Inc. (NASDAQ:SANA) Trading At A 38% Discount?
Oct 13Sana Biotechnology: Hypoimmune Cell Therapies
Jul 01Sana Biotechnology reports Q1 results
May 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -334 | -267 | -188 | 4 |
12/31/2025 | N/A | -289 | -244 | -183 | 4 |
12/31/2024 | N/A | -277 | -168 | -199 | 4 |
6/30/2024 | N/A | -245 | -285 | -240 | N/A |
3/31/2024 | N/A | -309 | -274 | -240 | N/A |
12/31/2023 | N/A | -283 | -274 | -254 | N/A |
9/30/2023 | N/A | -276 | -288 | -278 | N/A |
6/30/2023 | N/A | -362 | -292 | -279 | N/A |
3/31/2023 | N/A | -320 | -307 | -292 | N/A |
12/31/2022 | N/A | -269 | -311 | -290 | N/A |
9/30/2022 | N/A | -300 | -346 | -324 | N/A |
6/30/2022 | N/A | -298 | -335 | -310 | N/A |
3/31/2022 | N/A | -207 | -310 | -279 | N/A |
12/31/2021 | N/A | -356 | -281 | -251 | N/A |
9/30/2021 | N/A | -358 | -212 | -179 | N/A |
6/30/2021 | N/A | -327 | -198 | -166 | N/A |
3/31/2021 | N/A | -433 | -183 | -158 | N/A |
12/31/2020 | N/A | -285 | -162 | -138 | N/A |
9/30/2020 | N/A | -215 | -155 | -134 | N/A |
12/31/2019 | N/A | -131 | -112 | -86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SANA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SANA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SANA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SANA is forecast to have no revenue next year.
High Growth Revenue: SANA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SANA is forecast to be unprofitable in 3 years.